Subscribe
Share
Share
Embed
This week’s episode will review a report on a new mouse model with an enhanced ability to support human hematopoietic and tumor engraftment, explore more about increased mTOR activation in idiopathic multicentric Castleman disease, and assess the feasibility and efficacy of CD19-targeted CAR-T cells with concurrent ibrutinib for CLL.
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.